Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- IBD0333Phase 21 trial
SUNHO(China)BioPharmaceutical CO., Ltd. · MTD
- IbezapolstatACX-362EPhase 21 trial
Acurx Pharmaceuticals Inc. · Clostridium Difficile Infection Recurrence
- IBI129Phase 21 trial
Innovent Biologics (Suzhou) Co. Ltd. · Solid Tumor
- IBI133Phase 21 trial
Innovent Biologics (Suzhou) Co. Ltd. · Locally Advanced Unresectable or Metastatic Solid Tumors
- IBI3002Phase 21 trial
Innovent Biologics (Suzhou) Co. Ltd. · Atopic Dermatitis
- IBI3005Phase 21 trial
Innovent Biologics (Suzhou) Co. Ltd. · Solid Tumor
- IBI3014Phase 21 trial
Innovent Biologics (Suzhou) Co. Ltd. · Unresectable Locally Advanced or Metastatic Solid Tumors
- IBI3016Phase 21 trial
Innovent Biologics (Suzhou) Co. Ltd. · Hypertension
- IBI305Phase 21 trial
Innovent Biologics (Suzhou) Co. Ltd. · EGFR Mutant NSCLC and Platinum Resistant Ovarian Cancer
- IBI334Phase 21 trial
Innovent Biologics (Suzhou) Co. Ltd. · Advanced Solid Tumors
- IBI355Phase 21 trial
Innovent Biologics (Suzhou) Co. Ltd. · Sjögren's Disease
- IBR854Phase 21 trial
Imbioray (Hangzhou) Biomedicine Co., Ltd. · Renal Cell Carcinoma (RCC)
- ICP-192Phase 21 trial
Beijing InnoCare Pharma Tech Co., Ltd. · Intrahepatic Cholangiocarcinoma (ICC)
- ICP-322Phase 21 trial
Beijing InnoCare Pharma Tech Co., Ltd. · Prurigo Nodularis (PN)
- ICP-490Phase 21 trial
Beijing InnoCare Pharma Tech Co., Ltd. · Relapsed or Refractory Non-Hodgkin Lymphoma
- ICT01Phase 21 trial
ImCheck Therapeutics, an Ipsen company · Solid Tumor, Adult, Hematopoietic/Lymphoid Cancer
- IDE161Phase 21 trial
IDEAYA Biosciences · Small-cell Lung Cancer, Neuroendocrine Carcinomas, Solid Tumor Show to Express DLL3
- IDE397Phase 21 trial
Amgen · MTAP-null Non-Small-Cell Lung Cancer, MTAP-null Solid Tumors
- IDE849Phase 21 trial
IDEAYA Biosciences · Small-cell Lung Cancer, Neuroendocrine Carcinomas, Solid Tumor Show to Express DLL3
- IDP-001Phase 21 trial
InduPro, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Head and Neck Squamous Cell Carcinoma
- IDP-023Phase 21 trial
Indapta Therapeutics, INC. · NHL, Multiple Myeloma, Blood Cancer
- IDX-1197Phase 21 trial
Idience Co., Ltd. · Gastric Cancer
- IG3018Phase 21 trial
Intelligem Therapeutics Australia Pty Ltd. · Hyperuricemia, Hypouricemia, Renal
- IGT-303Phase 21 trial
Ingenia Therapeutics INC · Healthy Volunteers, Chronic Kidney Disease
- ILKN421HPhase 21 trial
iLeukon Therapeutics, Inc. · Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- IlofotasePhase 21 trial
AM-Pharma · Open Heart Surgery
- IMA401Phase 21 trial
Immatics Biotechnologies GmbH · Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult
- IMA402Phase 21 trial
Immatics Biotechnologies GmbH · Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult
- IMGN151Phase 21 trial
AbbVie · Gynecologic Cancers, Platinum-Sensitive Ovarian Cancer, Fallopian Tube Cancer
- IMNN-101Phase 21 trial
Imunon · SARS CoV 2 Infection
- ImofinostatABT-301, MPT0E028Phase 21 trial
Anbogen Therapeutics, Inc. · Colorectal Cancer (Diagnosis), Colorectal Cancer Metastatic, Colorectal Cancer (CRC)
- IMP 08P2002F0Phase 21 trial
Unither Pharmaceuticals, France · Mydriasis
- IMP1734Phase 21 trial
Eikon Therapeutics · Advanced Solid Tumor
- IMP9064Phase 21 trial
Impact Therapeutics, Inc. · Solid Tumor, Advanced Solid Tumor
- IMT-009Phase 21 trial
Immunitas Therapeutics · Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer
- IN-207907Phase 21 trial
HK inno.N Corporation · Sarcopenia in Elderly
- INB301Phase 21 trial
Yunnan Baiyao Group Co., Ltd. · Cancer Cachexia
- INBRX-109Phase 21 trial
Inhibrx Biosciences, Inc · Conventional Chondrosarcoma
- INCA000585Phase 21 trial
Incyte · Immune Thrombocytopenia
- INDV-2000Phase 21 trial
Indivior Inc. · Opioid Use Disorder
- INDV-6001Phase 21 trial
Indivior Inc. · Moderate to Severe Opioid Use Disorder
- INI-2004Phase 21 trial
Inimmune Corporation · Allergic Rhinitis Due to Allergens, Rhinitis Allergic, Allergic Rhinitis
- INN imapextideMBX 1416Phase 21 trial
MBX Biosciences · Postbariatric Hypoglycemia
- INNA-051Phase 21 trial
ENA Respiratory Pty Ltd · Viral Respiratory Infection, Viral Respiratory Illnesses
- INP20Phase 21 trial
InnoUp Farma S.L. · Peanut Allergy
- INT-210Phase 21 trial
Innatus Therapeutics (Shanghai) Co., Ltd. · Ulcerative Colitis (UC)
- intraocular implant releasing timololTimoD implantPhase 21 trial
EyeD Pharma · Glaucoma, Ocular Hypertension
- INV-102Phase 21 trial
Invirsa, Inc. · Non-center Involved Diabetic Macular Edema, Non-center Involved Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy, Diabetic Retinopathy
- INV-6452Phase 21 trial
Shenzhen Ionova Life Sciences Co., Ltd. · Breast Cancer (Locally Advanced or Metastatic), Advanced Solid Cancers, Metastatic (Stage IV) Breast Cancer
- INV-8989Phase 21 trial
Shenzhen Ionova Life Sciences Co., Ltd. · Advance Solid Tumors, Colon and Rectal Cancer, Non - Small Cell Lung Cancer NSCLC
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.